|
Jul 18
|
Lilly's (LLY) Donanemab Slows Alzheimer's Disease Progression
|
|
Jul 17
|
2 Nasdaq Stocks That Could Soar This Week
|
|
Apr 26
|
Drug Heavyweights GSK, Roche Topple As Covid Weighs On Sales Growth
|
|
Apr 26
|
CHMP recommends EU approval of Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma
|
|
Apr 26
|
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
|
|
Apr 26
|
Roche (RHHBY) Q1 Revenues Decline on Lower COVID-19 Test Sales
|
|
Apr 26
|
GSK sales fall after demand for Covid treatment plummets
|
|
Apr 26
|
Roche CEO on New Drugs to Offset Post-Covid Drop
|
|
Apr 26
|
Roche Q1 sales decline tempered by swift uptake of new eye drug
|
|
Apr 26
|
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth in base business of both divisions in the first quarter; Group sales decline due to expected drop in demand for COVID-19 tests
|
|
Apr 25
|
New Vabysmo Data Suggest Greater Retinal Drying Versus Aflibercept in Wet Age-Related Macular Degeneration and Diabetic Macular Edema
|
|
Apr 25
|
New Vabysmo data suggest greater retinal drying versus aflibercept in nAMD and DME
|
|
Apr 24
|
Genentech Announces Industry-Leading Brain Health Research Collaborations and Latest Data Across Neuroscience Medicines at AAN 2023 Annual Meeting
|